239 related articles for article (PubMed ID: 24626595)
1. Effect of hypoxic stress on migration and characteristics of monocytes in uveal melanoma.
Bronkhorst IH; Jehs TM; Dijkgraaf EM; Luyten GP; van der Velden PA; van der Burg SH; Jager MJ
JAMA Ophthalmol; 2014 May; 132(5):614-21. PubMed ID: 24626595
[TBL] [Abstract][Full Text] [Related]
2. Inflammation-induced chemokine expression in uveal melanoma cell lines stimulates monocyte chemotaxis.
Jehs T; Faber C; Juel HB; Bronkhorst IH; Jager MJ; Nissen MH
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5169-75. PubMed ID: 25074768
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-124a is epigenetically regulated and acts as a tumor suppressor by controlling multiple targets in uveal melanoma.
Chen X; He D; Dong XD; Dong F; Wang J; Wang L; Tang J; Hu DN; Yan D; Tu L
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2248-56. PubMed ID: 23404119
[TBL] [Abstract][Full Text] [Related]
4. Monocytes and dendritic cells in a hypoxic environment: Spotlights on chemotaxis and migration.
Bosco MC; Puppo M; Blengio F; Fraone T; Cappello P; Giovarelli M; Varesio L
Immunobiology; 2008; 213(9-10):733-49. PubMed ID: 18926289
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of chemokine receptors on uveal melanoma cells and their metastases.
Li H; Alizadeh H; Niederkorn JY
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):636-43. PubMed ID: 18235009
[TBL] [Abstract][Full Text] [Related]
6. Secretion of interleukin-6 and prostaglandin E2 during uveal melanoma-monocyte in vitro interactions.
Cools-Lartigue J; Marshall JC; Caissie AL; Saraiva VS; Burnier MN
Exp Eye Res; 2004 Oct; 79(4):451-4. PubMed ID: 15381029
[TBL] [Abstract][Full Text] [Related]
7. Expression of Antimicrobial Peptides by Uveal and Cutaneous Melanoma Cells and Investigation of Their Role in Tumor Cell Migration and Vasculogenic Mimicry.
Manarang JC; Otteson DC; McDermott AM
Curr Eye Res; 2017 Nov; 42(11):1474-1481. PubMed ID: 28910167
[TBL] [Abstract][Full Text] [Related]
8. Induction of Chemokine Secretion and Monocyte Migration by Human Choroidal Melanocytes in Response to Proinflammatory Cytokines.
Jehs T; Faber C; Udsen MS; Jager MJ; Clark SJ; Nissen MH
Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6568-6579. PubMed ID: 27918831
[TBL] [Abstract][Full Text] [Related]
9. Regulation of VEGF-A in uveal melanoma.
el Filali M; Missotten GS; Maat W; Ly LV; Luyten GP; van der Velden PA; Jager MJ
Invest Ophthalmol Vis Sci; 2010 May; 51(5):2329-37. PubMed ID: 20042655
[TBL] [Abstract][Full Text] [Related]
10. Comparing the Hem- and Lymphangiogenic Profile of Conjunctival and Uveal Melanoma Cell Lines.
Refaian N; Schlereth SL; Koch KR; Notara M; Hos D; Mescher M; Iden S; Bosch JJ; Jager MJ; Cursiefen C; Heindl LM
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5691-7. PubMed ID: 26313304
[TBL] [Abstract][Full Text] [Related]
11. Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma.
Chen X; Wang J; Shen H; Lu J; Li C; Hu DN; Dong XD; Yan D; Tu L
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1193-9. PubMed ID: 21051724
[TBL] [Abstract][Full Text] [Related]
12. Fucoidan Does Not Exert Anti-Tumorigenic Effects on Uveal Melanoma Cell Lines.
Dithmer M; Kirsch AM; Richert E; Fuchs S; Wang F; Schmidt H; Coupland SE; Roider J; Klettner A
Mar Drugs; 2017 Jun; 15(7):. PubMed ID: 28640204
[TBL] [Abstract][Full Text] [Related]
13. Bone morphogenetic protein 7 inhibits tumor growth of human uveal melanoma in vivo.
Notting I; Buijs J; Mintardjo R; van der Horst G; Vukicevic S; Lowik C; Schalij-Delfos N; Keunen J; van der Pluijm G
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4882-9. PubMed ID: 17962434
[TBL] [Abstract][Full Text] [Related]
14. Effects of interleukin-1 receptor antagonist on tumor stroma in experimental uveal melanoma.
Triozzi PL; Aldrich W; Singh A
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5529-35. PubMed ID: 21519029
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia promotes uveal melanoma invasion through enhanced Notch and MAPK activation.
Asnaghi L; Lin MH; Lim KS; Lim KJ; Tripathy A; Wendeborn M; Merbs SL; Handa JT; Sodhi A; Bar EE; Eberhart CG
PLoS One; 2014; 9(8):e105372. PubMed ID: 25166211
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA 145 may play an important role in uveal melanoma cell growth by potentially targeting insulin receptor substrate-1.
Li Y; Huang Q; Shi X; Jin X; Shen L; Xu X; Wei W
Chin Med J (Engl); 2014; 127(8):1410-6. PubMed ID: 24762580
[TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation: a common cause of reduced p16(INK4a) expression in uveal melanoma.
van der Velden PA; Metzelaar-Blok JA; Bergman W; Monique H; Hurks H; Frants RR; Gruis NA; Jager MJ
Cancer Res; 2001 Jul; 61(13):5303-6. PubMed ID: 11431374
[TBL] [Abstract][Full Text] [Related]
18. [Cytokines in uveal melanoma. Original title: uveal melanoma cytokines].
Filer RS; Song JC; Char DH; Kaleta-Michaels S
Klin Monbl Augenheilkd; 1993 Mar; 202(3):174-9. PubMed ID: 8510410
[TBL] [Abstract][Full Text] [Related]
19. miR-367 promotes uveal melanoma cell proliferation and migration by regulating PTEN.
Ling JW; Lu PR; Zhang YB; Jiang S; Zhang ZC
Genet Mol Res; 2017 Aug; 16(3):. PubMed ID: 28829890
[TBL] [Abstract][Full Text] [Related]
20. Paracrine regulation of vascular endothelial growth factor--a expression during macrophage-melanoma cell interaction: role of monocyte chemotactic protein-1 and macrophage colony-stimulating factor.
Varney ML; Olsen KJ; Mosley RL; Singh RK
J Interferon Cytokine Res; 2005 Nov; 25(11):674-83. PubMed ID: 16318581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
